UroGen Pharma Ltd. (URGN)

UroGen Pharma Stock Forecast

Stock Price Forecast

According to 8 professional analysts, the 12-month price target for UroGen Pharma stock ranges from a low of $3.00 to a high of $47. The average analyst price target of $28.5 forecasts a 24.02% increase in the stock price over the next year.

Price Target: $28.50 (+24.02%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$3.00	$28.5	$31	$47
Change	-86.95%	+24.02%	+34.90%	+104.53%

* Price targets were last updated on Oct 27, 2025.

Analyst Ratings

The average analyst rating for UroGen Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	5	4	4	4	4	4
Buy	2	3	3	3	3	3
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $40	Strong Buy	Reiterates	$40	+74.06%	Oct 27, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $25	Strong Buy	Maintains	$25	+8.79%	Oct 27, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $25	Strong Buy	Maintains	$25	+8.79%	Oct 3, 2025
Kelsey Goodwin Piper Sandler	Piper Sandler	Buy Initiates $36	Buy	Initiates	$36	+56.66%	Aug 19, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $50 → $40	Strong Buy	Maintains	$50 → $40	+74.06%	Aug 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

115.67M

Increased by 27.96%

from 90.40M

Revenue Next Year

257.97M

Increased by 123.02%

from 115.67M

EPS This Year

-3.22

from -2.96

EPS Next Year

-0.74

from -3.22

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	11.80M	48.04M	64.36M	82.71M	90.40M	115.67M	257.97M
Revenue Growth	65,450.00%	307.17%	33.96%	28.52%	9.29%	27.96%	123.02%
EPS	-5.90	-4.96	-4.81	-3.55	-2.96	-3.22	-0.74
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	129.7M	411.1M
Avg	115.7M	258.0M
Low	102.7M	187.3M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	43.5%	255.4%
Avg	28.0%	123.0%
Low	13.6%	61.9%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-2.98	2.56
Avg	-3.22	-0.74
Low	-3.33	-1.70

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.